289
Participants
Start Date
February 28, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
March 31, 2010
Ad2/HIF-1α/VP16
a one time treatment of 20 IM injections of 0.01 ML each into each leg for a total of 40 injections
Ad2/HIF-1α/VP16
one time treatment of 20 IM injections of 0.01 ML each into each leg for a total of 40 injections.
Ad2/HIF-1α/VP16
a one time treatment of 20 IM injections of 0.01 ML each into each leg for a total of 40 injections.
Saline (Placebo Control)
a one time treatment of 20 IM injections of 0.01 ML each into each leg for a total of 40 injections.
New York University School of Medicine, New York
Mount Sinai School of Medicine, New York
Ev. Krankenhaus Königin Elisabeth, Berlin
Charité Campus Benjamin Franklin, Berlin
University of Rochester Medical Center, Rochester
The Washington Hospital Center, Washington D.C.
The Johns Hopkins Hospital, Baltimore
Universitätsklinikum Schleswig Holstein/Campus Luebeck, Lübeck
University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Saint Joseph's Research Institute, Atlanta
Baptist Health Care, Pensacola
Prairie Cardiovascular Consultants, Ltd., Springfield
Palm Beach Heart Institute, Atlantis
University of South Florida, Tampa
Baptist Medical Center Princeton, Birmingham
Jobst Vascular Center, Toledo
Medical University of Ohio, Toledo
Cleveland Clinic Foundation, Cleveland
The Care Group at the Heart Center, Indianapolis
Henry Ford Hospital, Detroit
Universitätsklinikum Munster, Münster
Minneapolis Heart Institute Foundation, Minneapolis
Rush University Medical Center, Chicago
Saint Louis University Hospital, St Louis
Ochsner Clinic Foundation, Metairie
University of Oklahoma, Health Sciences Center, Oklahoma City
Baylor University Medical Center, Dallas
Klinikum Karlsbad Langensteinbach gGmbH, Karlsbad
Baylor College of Medicine, Houston
Peripheral Vascular Associates, San Antonio
University of Colorado Health Sciences Center, Denver
Klinikum Grosshadern, Munich
VA Palo Alto Health Care System, Palo Alto
Stanford University School of Medicine, Stanford
University of California at Davis, Sacramento
Oregon Health & Science University, Portland
Massachusetts General Hospital, Boston
Boston Medical Center, Boston
Caritas St. Elizabeth's Medical Center, CCP4C, Boston
Dartmouth-Hitchcock Medical Center, Lebanon
Belfast City Hospital, Belfast
Selly Oak Hospital, Birmingham
Ninewells Hospital & Medical School, Dundee
Hull Royal Infirmary, Hull
St. George's Hospital and Medical School, London
Ealing Hospital, Southall, Middlesex
Genzyme, a Sanofi Company
INDUSTRY